Skip to content
10-Q

Quarterly Report

DERMA SCIENCES, INC.

0001144204-16-132884

← back to feed
Filed
Nov 9, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 8, 2016 28.27M sh
Capex Q3 2016 · Sep 30, 2016 $235.13K
Capex Q3 2016 · Sep 30, 2015 $1.14M
Short Term Investments Q3 2016 · Sep 30, 2016 $15M
Short Term Investments Q3 2016 · Dec 31, 2015 $25M
Cash And Equivalents Q3 2016 · Sep 30, 2016 $25.97M
Cash And Equivalents Q3 2016 · Dec 31, 2015 $15.81M
Cash And Equivalents Q3 2016 · Sep 30, 2015 $14.43M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $19.4M
Stockholders Equity Q3 2016 · Sep 30, 2016 $112.41M
Stockholders Equity Q3 2016 · Dec 31, 2015 $98.43M
Current Liabilities Q3 2016 · Sep 30, 2016 $53.59M
Current Liabilities Q3 2016 · Dec 31, 2015 $14.49M
Total Liabilities Q3 2016 · Sep 30, 2016 $68.48M
Total Liabilities Q3 2016 · Dec 31, 2015 $17.31M
Current Assets Q3 2016 · Sep 30, 2016 $69.26M
Current Assets Q3 2016 · Dec 31, 2015 $72.06M
Total Assets Q3 2016 · Sep 30, 2016 $180.89M
Total Assets Q3 2016 · Dec 31, 2015 $115.73M
Rd Expense Q3 2016 · Sep 30, 2016 $76.27K
Rd Expense Q3 2016 · Sep 30, 2016 $76.27K
Rd Expense restated Q3 2016 · Sep 30, 2015 $120.39K
Rd Expense restated Q3 2016 · Sep 30, 2015 $703.51K
Net Income Q3 2016 · Sep 30, 2016 −$1.39M
Net Income Q3 2016 · Sep 30, 2016 −$1.17M
Net Income Q3 2016 · Sep 30, 2015 −$8.96M
Net Income Q3 2016 · Sep 30, 2015 −$28.86M
Operating Income Q3 2016 · Sep 30, 2016 −$5.8M
Operating Income Q3 2016 · Sep 30, 2016 −$10.92M
Operating Income restated Q3 2016 · Sep 30, 2015 −$5.05M
Operating Income restated Q3 2016 · Sep 30, 2015 −$17.7M
Gross Profit Q3 2016 · Sep 30, 2016 $10.71M
Gross Profit Q3 2016 · Sep 30, 2016 $24.77M
Gross Profit restated Q3 2016 · Sep 30, 2015 $7.3M
Gross Profit restated Q3 2016 · Sep 30, 2015 $21.06M
Cost Of Revenue Q3 2016 · Sep 30, 2016 $11.1M
Cost Of Revenue Q3 2016 · Sep 30, 2016 $30.75M
Cost Of Revenue restated Q3 2016 · Sep 30, 2015 $10.49M
Cost Of Revenue restated Q3 2016 · Sep 30, 2015 $30.31M
Stock Issued Q3 2016 · Aug 5, 2016 551.67K sh